Functions of the central nervous system are suppressed by the administration of a type of drug derived from barbituric acid, known as barbiturate anticonvulsant drugs. The GABA is the chief inhibitory compound in the mature vertebrate central nervous system that responds to the neurotransmitter gamma-aminobutyric acid (GABA). The action of GABA is enhanced by barbiturate anticonvulsants. Seizure is a sudden attack of illness, especially a stroke or an epileptic fit. Also, GABA inhibits initiation of discharge that would start the seizure, as it is an inhibitory neurotransmitter. Effectiveness of GABA is increased as barbiturate facilitates GABA-mediated opening of chloride channels. Except absence seizures, all other types of seizures can be treated by barbiturates.

Seizures are also known as convulsions. A patients under seizure loses control over his actions due to sudden attack of brain activity. During seizure, patients experience jerking of legs, arms, or face. Various types of seizures may occur to people, irrespective of age, and can last for few seconds to minutes. Minor seizure can also be extremely risky when it occurs to a person while driving or swimming. Seizures that affect only one part of the brain are known as simple partial seizures or simple focal seizures. During seizure, there may be loss of awareness, loss of memory, or mental confusion; such seizures are known as dyscognitive focal seizures.

Rising prevalence of seizures across the world is driving the growth of the global barbiturate anticonvulsant drugs market. According to Healthline Media and Epilepsy Foundation of America, who forecasted same thing that every year, approximately 150,000 people in the U.S. are diagnosed with central nervous system disorders which lead to seizures. Healthline Media also states that one in 26 people will be diagnosed with seizures over a lifetime. Epilepsy is defined as having two or more unprovoked seizures. According to the World Health Organization (WHO), up to 10% of the world population has one seizure during a lifetime. The WHO also states that there are about 50 million people worldwide presently living with epilepsy. Every year, 30 to 50 per 100000 people are newly diagnosed with epilepsy in high-income countries, and this count is approximately two times higher among low and middle income countries. Ketogenic diet is anticipated to restrain the growth of the global barbiturate anticonvulsants drugs market to a certain extent. According to a study published by the National Center for Biotechnology Information, ketogenic diet reduces the chances of seizures in children.

The global barbiturate anticonvulsant drugs market can be categorized into indication, distribution channel, and region. In terms of indication, the market can be classified into generalized seizures and focal (partial) seizures. Generalized seizures can further be classified into tonic-clonic seizure, atonic seizure, myoclonic seizure, clonic seizure, and tonic seizure. Focal seizures can further be classified into dyscognitive focal seizures and simple focal seizures. Based on distribution channel, the barbiturate anticonvulsant drugs market can be divided into retail pharmacies, online pharmacies, and hospital pharmacies.

Geographically, the global barbiturate anticonvulsant drugs market can be categorized into Latin America, Asia Pacific, Europe, North America, and Middle East & Africa. North America held the large market share in 2017, due to new drug launches and increase in research and development on barbiturate anticonvulsant drugs in the region. Europe held the second leading market share in 2017, owing to increase in awareness programs and promotional activities conducted by the key players in the region. Asia Pacific is anticipated to grow at a significant rate during the forecast period owing to increase in government initiatives to create awareness regarding the barbiturate anticonvulsant drugs, especially in countries, such as China and India. Japan held the maximum share of the barbiturate anticonvulsant drugs market in Asia Pacific in 2017, owing to the large geriatric population in the country. The barbiturate anticonvulsant drugs market in Middle East & Africa and Latin America is anticipated to grow at a moderate rate during the forecast period owing to rise in government initiatives regarding development of and creating awareness barbiturate anticonvulsants drugs in the regions.

Key players operating in the global barbiturate anticonvulsants drugs market include GlaxoSmithKline plc, Astellas Pharma Technologies Inc., Valeant Pharmaceuticals N.A., and Watson Laboratories, Inc.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Barbiturate Anticonvulsant Drugs Market